These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 30428391)

  • 1. Validation of the International Tumor Budding Consensus Conference 2016 recommendations on tumor budding in stage I-IV colorectal cancer.
    Dawson H; Galuppini F; Träger P; Berger MD; Studer P; Brügger L; Zlobec I; Inderbitzin D; Lugli A
    Hum Pathol; 2019 Mar; 85():145-151. PubMed ID: 30428391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic and predictive values of tumour budding in stage IV colorectal cancer.
    Nagata K; Shinto E; Yamadera M; Shiraishi T; Kajiwara Y; Okamoto K; Mochizuki S; Hase K; Kishi Y; Ueno H
    BJS Open; 2020 Aug; 4(4):693-703. PubMed ID: 32472647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumour budding in pancreatic cancer revisited: validation of the ITBCC scoring system.
    Karamitopoulou E; Wartenberg M; Zlobec I; Cibin S; Worni M; Gloor B; Lugli A
    Histopathology; 2018 Jul; 73(1):137-146. PubMed ID: 29495092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Refining the ITBCC tumor budding scoring system with a "zero-budding" category in colorectal cancer.
    Zlobec I; Bächli M; Galuppini F; Berger MD; Dawson HE; Nagtegaal ID; Lugli A
    Virchows Arch; 2021 Dec; 479(6):1085-1090. PubMed ID: 33843013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor budding in colorectal carcinoma: An institutional interobserver reliability and prognostic study of colorectal adenocarcinoma cases.
    Hacking S; Angert M; Jin C; Kline M; Gupta N; Cho M; Thomas R; Lee L; Chavarria H; Nasim M
    Ann Diagn Pathol; 2019 Dec; 43():151420. PubMed ID: 31731034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reporting of tumor budding in colorectal adenocarcinomas using ×40 objective: A practical approach for resource constrained set-ups.
    Roy P; Datta J; Roy M; Mallick I; Mohandas M
    Indian J Cancer; 2017; 54(4):640-645. PubMed ID: 30082550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of tumor budding in gallbladder cancer: application of the International Tumor Budding Consensus Conference scoring system.
    Kim HN; Lee SY; Kim BH; Kim CY; Kim A; Kim H
    Virchows Arch; 2021 Jun; 478(6):1071-1078. PubMed ID: 33398430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of tumour budding on adjuvant chemotherapy in colorectal cancer.
    Xie H; Zeng Z; Hou Y; Ye F; Cai T; Cai Y; Xiong L; Li W; Liu Z; Liang Z; Luo S; Zheng X; Huang L; Liu H; Kang L
    BJS Open; 2024 Jan; 8(1):. PubMed ID: 38190579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Should a fourth category be added to the international tumor budding consensus conference tumor budding scoring system in colorectal adenocarcinomas?
    Secinti IE; Ozgur T; Gursoy D; Dede I
    APMIS; 2022 Sep; 130(9):560-567. PubMed ID: 35816469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of the International Tumor Budding Consensus Conference (ITBCC) 2016 recommendation in squamous cell carcinoma of the lung-a single-center analysis of 354 cases.
    Neppl C; Zlobec I; Schmid RA; Berezowska S
    Mod Pathol; 2020 May; 33(5):802-811. PubMed ID: 31796876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016.
    Lugli A; Kirsch R; Ajioka Y; Bosman F; Cathomas G; Dawson H; El Zimaity H; Fléjou JF; Hansen TP; Hartmann A; Kakar S; Langner C; Nagtegaal I; Puppa G; Riddell R; Ristimäki A; Sheahan K; Smyrk T; Sugihara K; Terris B; Ueno H; Vieth M; Zlobec I; Quirke P
    Mod Pathol; 2017 Sep; 30(9):1299-1311. PubMed ID: 28548122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of tumour budding in stomach cancers.
    Kucuk S
    Int J Clin Pract; 2021 Dec; 75(12):e14922. PubMed ID: 34580963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Tumor Budding in Predicting Survival for Gastric Carcinoma Patients in Vietnam.
    Dao TV; Nguyen CV; Nguyen QT; Vu HTN; Phung HT; Bui OT; Nguyen DK; Luong BV; Tran TV
    Cancer Control; 2020; 27(1):1073274820968883. PubMed ID: 33136444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effect of tumor budding on the benefit of adjuvant chemotherapy in stage II colorectal cancer: a retrospective observational study.
    Ran X; Chen Y; Liu C; Xiao H; Su X; Chen Z; Du J; He J; Zhong P; Li M; Dai N; Chen C
    J Gastrointest Oncol; 2024 Aug; 15(4):1545-1555. PubMed ID: 39279933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor budding assessed according to the criteria of the International Tumor Budding Consensus Conference determines prognosis in resected esophageal adenocarcinoma.
    Lohneis P; Hieggelke L; Gebauer F; Ball M; Bruns C; Büttner R; Löser H; Quaas A
    Virchows Arch; 2021 Mar; 478(3):393-400. PubMed ID: 32761393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor budding and poorly-differentiated cluster in prognostication in Stage II colon cancer.
    Lee VWK; Chan KF
    Pathol Res Pract; 2018 Mar; 214(3):402-407. PubMed ID: 29487008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of tumour budding assessed in gastric carcinoma according to the criteria of the International Tumour Budding Consensus Conference.
    Ulase D; Heckl S; Behrens HM; Krüger S; Röcken C
    Histopathology; 2020 Feb; 76(3):433-446. PubMed ID: 31538348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Relationship Between Tumor Budding, Tumor Microenvironment, and Survival in Patients with Primary Operable Colorectal Cancer.
    van Wyk HC; Roseweir A; Alexander P; Park JH; Horgan PG; McMillan DC; Edwards J
    Ann Surg Oncol; 2019 Dec; 26(13):4397-4404. PubMed ID: 31605345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor budding is an independent prognostic factor in stage III colon cancer patients: a post-hoc analysis of the IDEA-France phase III trial (PRODIGE-GERCOR).
    Basile D; Broudin C; Emile JF; Falcoz A; Pagès F; Mineur L; Bennouna J; Louvet C; Artru P; Fratte S; Ghiringhelli F; André T; Derangère V; Vernerey D; Taieb J; Svrcek M;
    Ann Oncol; 2022 Jun; 33(6):628-637. PubMed ID: 35306156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increasing tumor budding in cholangiocarcinoma is associated with decreased disease-specific survival.
    Agostini-Vulaj D; Cates JMM; Bratton LE; Gonzalez RS
    Hum Pathol; 2021 May; 111():75-83. PubMed ID: 33727168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.